Date:6/13/2010

Biotics, Inc. ("China-Biotics," "the Company"), a leading manufacturer of biotechnology products and supplements, engages in the research, development, marketing and distribution of probiotics dietary supplements in China. Through its wholly owned subsidiary, Shanghai Shining Biotechnology Co., Ltd., the Company develops and produces its proprietary product portfolio including live microbial nutritional supplements under the "Shining" brand. Currently, the products are sold OTC through large distributors to pharmacies and supermarkets in Shanghai, Jiangsu, and Zhejiang province. In February 2010, China-Biotics began its commercial production in China's largest probiotics production facility to meet growing demand in China. For more information, please visit http://www.chn-biotics.com .

Safe Harbor Statement

The information in this release contains forward-looking statements which involve risks and uncertainties, including statements regarding the Company's capital needs, business strategy and expectations. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements, which may be identified by terminology such as "may," "should," "will," "expect," "plan," "intend," "anticipate," "believe," "estimate," "predict," "potential," "forecast," "project," or "continue," the negative of such terms or other comparable terminology. Readers should not rely on forward-looking statements as predictions of futu
'/>"/>

SOURCE China-Biotics, Inc. Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Related biology technology :

1. China-Biotics, Inc. Appointed Grayling as Strategic Investor Relations Advisor
2. China-Biotics, Inc. Inaugurated the Commercial Production of its New Production Facility
3. China-Biotics, Inc. Reports Third Quarter Fiscal 2010 Financial Results
4. China-Biotics, Inc. Announces Conference Call to Discuss Second Quarter Fiscal 2010 Financial Results
5. China-Biotics, Inc. Appoints New Vice President
6. China-Biotics, Inc. to Attend the SIG 3rd Annual Beijing Management Summit
7. China-Biotics, Inc. Reports First Quarter Fiscal 2010 Financial Results
8. China-Biotics, Inc. Receives High-Technology Enterprise Certification to Qualify for Preferential Income Tax Rate
9. China-Biotics, Inc. Applies for Four Patents on Probiotic Formulations
10. China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results
11. China-Biotics, Inc. Announces Conference Call to Discuss Fourth Quarter and Full Year 2009 Financial Results